Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Nonoxinol-9 may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
FOR Gygel is called a spermicidal contraceptive since it kills sperm. It should be used along with a barrier method of contraception, such as a vaginal diaphragm or cap, in order to prevent pregnancy. How does Gygel work? Following sex, pregnancy may occur if a sperm travels up the vagina and through the entrance to the womb (cervix) and beyond, where it might fertilise an egg. By using a vaginal diaphragm or cap, access to the cervix is blocked, preventing the passage of sperm into the womb. Spermicidal contraceptives such as Gygel will kill any sperm that may get round a diaphragm, and so will provide more effective contraception.
2. BEFORE YOU USE GYGEL Do not use Gygel if you:
GYGEL
4. POSSIBLE SIDE EFFECTS Like all medicines, Gygel can cause side effects, although not everybody gets them.
What if Gygel Contraceptive Jelly is swallowed? Gygel should only be used in the vagina. If put in the mouth, it is likely to taste unpleasant. However, if large quantities are accidentally swallowed, it may cause stomach irritation. In this case you should seek immediate help from the nearest hospital casualty department.
not listed in this leaflet, please tell your doctor or pharmacist.
This leaflet was last prepared in December 2013
Manufacturer: PHARBIL Waltrop GmbH, Im Wirrigen 25, D-45731, Waltrop, Germany
GYGEL Keep out of the sight and reach of children.
6. FURTHER INFORMATION What Gygel contains The active ingredient in Gygel is nonoxinol-9 2.0% w/w. The other ingredients are: methyl parahydroxybenzoate (E 218), Sorbitol solution (E 420), lactic acid, Povidone K30, propylene glycol, sodium carboxymethylcellulose, Sorbic acid (E 200) and purified water. What Gygel looks like and the contents of the pack Gygel is available in an aluminium tube containing a clear odourless vaginal gel. A Vaginal Applicator is available separately. Gygel is available in a 30g or 81g tube. Marketing Authorisation holder: Marlborough Pharmaceuticals Ltd, 35A High Street, Marlborough, Wilts, SN8 1LW, UK Tel 01672 514187
For information in large print, tape, CD or Braille, telephone 01672 514187
If any of the side effects gets serious, or if you notice any
The active substance in Gygel Contraceptive Jelly is nonoxinol-9.
This leaflet reproduces the patient information leaflet approved for Gygel Contraceptive Jelly, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
For use as a spermicidal contraceptive in conjunction with barrier methods of contraception such as diaphragms or caps.
Method of Administration
For vaginal use.For use by adult females only. Posology In order to prevent pregnancy, diaphragms and caps need to be used with a spermicide.Diaphragms: Approximately two 2cm strips of Gygel should be put on each side of the diaphragm. Putting a little on the rim also makes the diaphragm easier to insert. Caps: One-third of the cap should be filled with Gygel. The gel should also be placed in the groove between the dome and the rim of silicone caps. Gygel should not be put around the rim however as this will stop the cap from staying in place. Depending on the type of cap, extra Gygel may be required after the cap has been inserted.Extra Gygel will need to be added if coitus takes place 3 hours or more after insertion of a diaphragm or cap. The diaphragm /cap and spermicide must be allowed to remain undisturbed for at least six hours after coitus. A fresh application of gel or other spermicides, must be made prior to any subsequent acts of coitus within this period of time, without removing the diaphragm / cap.A vaginal applicator should be used for inserting more jelly.Douching is not recommended, but if desired it should be deferred for at least six hours after intercourse.
Hypersensitivity to nonoxinol-9 or to any component of the preparation.Patients with absent vaginal sensation e.g. paraplegics and quadriplegics.
Spermicidal intravaginal preparations are intended for use in conjunction with barrier methods of contraception such as diaphragms and caps. Gygel is not required for use with condoms as there is no evidence of any additional protection against pregnancy.Where avoidance of pregnancy is important, the choice of contraceptive method should be made in consultation with a doctor or a family planning clinic.This product does not protect against HIV (AIDS) or other sexually transmitted diseases (STDs). A latex condom should be used to protect against the spread of STDs. High frequency use of nonoxinol-9 has been reported to cause epithelial damage and increase the risk of HIV infection. Therefore women at risk of HIV/STD infection and who have multiple daily acts of intercourse should be advised to choose another method of contraception. Sexually active women should consider their individual HIV/STD infection risk when choosing a method of contraception.If vaginal or penile irritation occurs, discontinue use. If symptoms worsen or continue for more than 48 hours, medical advice should be sought.A diaphragm should not be left in the vagina for longer than 24 hours.
Some vaginal products and lubricating agents may contain ingredients that can damage contraceptive diaphragms/caps made from latex rubber. As a result these may be less effective as a barrier against pregnancy and as a protection from sexually transmitted diseases including HIV.The following products should NOT be used at the same time as a vaginal diaphragm or cap:• Petroleum jelly (Vaseline);• Mineral oil (baby oil);• Oil-based vaginal and rectal preparations.
There is no evidence from animal and human studies that nonoxinol-9 is teratogenic. Human epidemiological studies have not shown any firm evidence of adverse effects on the foetus, however some studies have shown that nonoxinol-9 may be embryotoxic in animals. This product should not be used if pregnancy is suspected or confirmed. Animal studies have detected nonoxinol-9 in milk after intravaginal administration. Use by lactating women has not been studied.
None known.
Nonoxinol-9 has been reported to cause epithelial damage and increase the risk of HIV infection.It may cause hypersensitivity and application site reactions such as irritation, pain, discomfort, burning sensation, itching, dryness, rash and redness of the vulva, vagina or penis.
If taken orally, the surfactant properties of this preparation may cause gastric irritation. General supportive therapy should be carried out. Hepatic and renal function should be monitored if medically indicated.
Ask anything about Gygel Contraceptive Jelly. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.